Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603148 · ClinicalTrials.gov registry record
The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications
A clinical trial of Genetic Polymorphism, sponsored by Vanderbilt University.
- Completed
- Registry status
- 475
- Enrollment target
- 1
- Study location
NCT00603148: Completed study of Genetic Polymorphism, sponsored by Vanderbilt University.
NCT00603148 is a study of Genetic Polymorphism that has completed, run by Vanderbilt University. The registered enrollment target is 475 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00603148, a study of Genetic Polymorphism, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 475 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will begin to define these critical determinants for patients undergoing procedures in the hybrid interventional cardiology/cardiac surgery suite. In future studies, the data obtained from this study will be used to prospectively stratify patients in terms of bleeding verses thrombotic risk to design studies to optimize anticoagulation and anti-platelet therapies in the hybrid setting.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 475 participants |
| Start Date | 2006-09 |
| Est. Completion | 2010-02 |
What the finished NCT00603148 record still lists
NCT00603148 is an observational study that tracks outcomes without assigning an intervention. The registered 475 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Genetic Polymorphism appearing as the primary indexed condition, and to 0 interventions.
NCT00603148 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00603148 about?
NCT00603148 is a clinical study titled "The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications". This study will begin to define these critical determinants for patients undergoing procedures in the hybrid interventional cardiology/cardiac surgery suite. In future studies, the data obtained from this study will be used to prospectively stratify patients in terms of bleeding verses thrombotic ri...
What is the current status of trial NCT00603148?
This trial is currently completed. The enrollment target is 475 participants. The study started on 2006-09. Estimated completion is 2010-02.
What conditions does trial NCT00603148 study?
This clinical trial studies the following conditions: Genetic Polymorphism.
Who is sponsoring clinical trial NCT00603148?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00603148 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Polymorphism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01788839 · 475 participants
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- NCT05451303 · 475 participants
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
- NCT06892379 · 475 participants · Phase 1
A Study of HS-20110 in Participants With Advanced Solid Tumors
- NCT06754046 · 476 participants · NA
BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia